NPS Board Members
Mr Peter Turner
Peter has over 40 years experience in the biopharmaceutical industry. He has been an executive director and chief operating officer of CSL Limited and was the founding president of CSL Behring purchased from Aventis in 2004.
Peter worked in Europe and the United States from 2000 to mid-2011 and was responsible for the integration and performance of several international businesses acquired by CSL.
Prior to moving overseas Peter oversaw the design, construction and operation of CSL's state-of-the-art $250M plasma fractionation manufacturing facility in Melbourne.
His expertise includes international healthcare, managing global business expansion, blood plasma therapies, protein separation technologies, pharmaceutical product development and quality assurance and industrial scale biotechnology.
Peter is a past chairman and board member of the PPTA (Plasma Protein Therapeutics Association) and is a current non executive director of Virtus Health Limited and a graduate member of the Australian Institute of Company Directors.
Peter was appointed to the NPS MedicineWise Board in December 2012 and held the position of NPS MedicineWise commercial committee chair until November 2014.
He has been chair of the NPS MedicineWise Board since 1 January 2015.
Andrew works as a general practitioner in Katoomba in the Blue Mountains and as a staff specialist in general practice at the GP Unit Fairfield Hospital. He has worked as a medical educator in the Australian General Practice Training Program for the Royal Australian College of General Practitioners and WentWest. He continues to train general practitioner registrars within his practice.
Andrew holds positions as senior lecturer in general practice at the University of NSW, University of Sydney and the University of Western Sydney. He is the chair of the Expert Reference Panel on Access for the Australian Primary Care Collaborative and is a director of the Nepean Blue Mountains Medicare Local.
Andrew's academic interests and areas of publication include quality improvement in general practice, medical education, and the role of general practitioners in the care of patients with rare diseases.
He is a fellow of the Australian Institute of Company Directors and member of the NPS MedicineWise Audit and Risk Committee
Jim's career over the past 30 years has been in higher education administration, specialising for over 20 years in international education, entrepreneurship in higher education and business management.
Until early 2009, he held the joint appointments of Vice Principal (international) at the University of Wollongong (UOW) and CEO/Managing Director of the ITC group of companies (UOW's commercial arm).
Jim brings to the NPS Board experience gained from directorships of organisations in the private education sector, entrepreneurial start-up companies and those involved in regional and economic development. His experience in offshore markets is diverse, in particular in the Middle East, South Asia and North America.
His qualifications include a doctorate from the University of Southhampton on the topic 'Entrepreneurship in higher education'. He was awarded a fellowship of the UOW in recognition of his contribution to international higher education and is also a fellow of the Australian Institute of Company Directors.
Jim is a member of both the NPS MedicineWise Audit and Risk Committee.
Winston is a practicing medical oncologist and clinical pharmacologist with a master's degree in pharmaceutical development. His clinical practice is based around gastrointestinal cancer with a speciality in regional and intraperitoneal chemotherapy. In 2013 he was appointed Director of the Cancer Services Stream South Eastern Sydney Local Health District.
His research is based in cancer pharmaceutical development and he is currently a principal or co-investigator on numerous industry and investigator initiated clinical trials, including phase 1 research. In this capacity he has provided consulting services for the biotechnology industry and contract research organisations. He is a conjoint associate professor of medicine at the University of New South Wales.
He has been heavily involved in research ethics and regulation. He has a post graduate degree in public policy.
Winston has published the results of clinical trials, cancer outcomes research, clinical trial conduct, the pharmacology of alternative medicines and surgical and locoregional therapies for cancer. His other interests include medical education, e-health, supportive care and pharmacogenetics.
He is Oncology Program Chair at the NSW Health Education and Training Institute (HETI) and serves on scientific advisory boards for the St George and Sutherland Medical Research Foundation and the Palliative Care Clinical Studies Collaborative.
Winston is a member of the NPS MedicineWise Board Governance and Nomination Committee.
Kay is an associate professor in the School of Nursing and Midwifery, University of South Australia. She is an experienced and active researcher and has been successful in nationally-funded research projects for the National Health and Medical Research Council and Australian Research Council. The focus of her research is specifically related to ageing and the provision of health services to deal with complexities associated with living life as we grow older and living with chronic conditions, integrating biomedical and social understandings of health to progress positive health and social care outcomes for society and its members and, to promote quality use of medicines and tests.
Kay is research leader, Safety & Quality in Health Research Group, School of Nursing & Midwifery, and a member of the National Research Council, Asthma Australia. She is a chief investigator on the North West Adelaide Health (Cohort) Study (NWAHS), a longitudinal, representative population biomedical cohort study established to examine chronic diseases and lifestyle risk factors. Kay is and a graduate of the Australian Institute of Company Directors.
Kay is chair of the NPS MedicineWise Board Governance and Nomination Committee.
Ms Debbie Rigby
Debbie is a consultant clinical pharmacist practicing in Brisbane. She is an internationally recognised certified geriatric pharmacist, having a special interest in geriatric pharmacotherapy, and regularly conducts medication review services and presentations to pharmacists, nurses, allied health professionals and consumers.
Debbie is a member of Australian Therapeutic Goods Advisory Council (ATGAC) and the Department of Health and Ageing Natural Therapy Review Advisory Committee. Debbie is an adjunct senior lecturer at the School of Pharmacy, University of Queensland and a Honorary Fellow, Queensland University of Technology.
Debbie's work is award-winning, earning her an Amrad Pharmacy Specialisation Grant by Society of Hospital Pharmacists of Australia in 1999, the PSA Australian Pharmacist of the Year in 2001, the PSA Qld Bowl of Hygeia in 2002, and the inaugural AACP Consultant Pharmacist Award in 2008.
Debbie is the Chair of the NPS MedicineWise Audit and Risk Committee.
Christine is CEO of Chronic Illness Alliance Inc, a peak body representing more than 50 consumer and advocacy organisations for people with chronic illness. The Alliance works with a number of other organisations and consults with consumers and consumer groups to build a better focus in health policy and health services for all people with chronic illness.
In 1995 Christine completed a PhD thesis exploring the growth of government intervention in the hospital system in Victoria. She has experience in qualitative research and has published a book on chronic illness as well as many journal articles. Her two most recent edited books are on social issues in epilepsy.
Christine is a board member of the Epilepsy Foundation of Victoria, Treasurer of Epilepsy Australia, and on the Advisory group of the UNSW Research Centre for Primary Health Care and Equity.
Christine is a member of the Audit and Risk Committee.
Dr Roger Sexton
Dr Sexton has practised as a procedural rural general practitioner in the Adelaide hills for 30 years. He is currently working in both part-time urban general practice and as a rural general practice locum. He also works as a medical consultant in executive health. He is a clinical skills tutor at Adelaide University Medical School and has a strong and long-standing interest in the professional education of medical students and doctors.
Roger has a personal commitment to lifelong learning and is currently completing his MBA at Adelaide University.
He has been a very recent member of the Pharmaceutical Benefits Advisory Committee from 2010-13 which includes the quality use of medicines in its decision making.
He was the last Presiding Member of the Medical Board of South Australia prior to chairing the new South Australian Board of the Medical Board of Australia. This encouraged his special interest in promoting professionalism and ethics in medicine and the importance of ongoing medical education and optimising the health of the medical profession for the good of the community.
Dr Sexton has been a strong advocate for improving the health of doctors locally and nationally and is the inaugural Medical Director of Doctors' Health SA.
He sits on the boards of the national medical indemnity insurer MIGA and its Claims Committee and until recently enjoyed membership of the federal AMA Council of General Practice.
Roger is a member of the NPS Audit and Risk Committee.
Debra brings to the Board her extensive personal and professional experience and commitment to positioning consumers at the centre of health policy, programs and services; supporting patients and carers as respected partners in their health care; and promoting safety and quality in health care.
Debra originally trained as a teacher, specialising in curriculum and research that included drug education, sexual health, safety and mental health. She established cross sectoral policy, training and services for people with physical and mental health care needs. Her responsibilities encompassed collaborative work with families and communities to implement community care protocols and education in areas that included medication, asthma, diabetes, epilepsy, anaphylaxis, mental health and complex community health care management.
Debra is a member of the NPS Board Governance and Nomination Committee.